This Author published in this journals
All Journal Jurnal Fisika Unand
Aulia Miftahul Jannah
Departemen Fisika, Fakultas Matematika dan Ilmu Pengetahuan Alam, Universitas Andalas

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

Analisis Dosis Radiasi Kanker Paru Menggunakan Teknik Intensity Modulated Radiotherapy untuk Minimalisasi Paparan Organ at Risk Aulia Miftahul Jannah; Rico Adrial; Fiqi Diyona; Muhammad Ilyas
Jurnal Fisika Unand Vol 15 No 5 (2026)
Publisher : Universitas Andalas

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.25077/jfu.15.5.529-535.2026

Abstract

Radiation dose analysis of lung cancer using intensity modulated radiotherapy technique has been conducted to minimize exposure to organs at risk. The study was conducted using 5 images of lung cancer patients processed using Eclipse Treatment Planning System (TPS) software at Andalas University Hospital. This study was conducted to determine the radiation dose distribution in lung cancer patients by analyzing the value of Conformity Index (CI), Homogeinity Index (HI), Organ at Risk (OAR) radiation dose based on the Dose Volume Histogram (DVH) curve and the maximum dose received by Planning Target Volume (PTV) based on the results of therapy planning. The analysis is based on the International Commission on Radiation Units and Measures (ICRU) Report 62 and Report 83 for CI and HI values. Radiation dose in OAR lungs and heart was analyzed based on the Quantitative Analysis of Normal Tissue Effect in the Clinic (QUANTEC) reference. The results of the study for CI values obtained values close to 1 based on ICRU Report 62 and HI values close to 0 based on ICRU Report 83. The radiation dose received by the heart OAR is in accordance with the QUANTEC recommendation of <10% while the radiation dose received by the lung OAR there are 2 patients who exceed the volume limit recommended by QUANTEC which is <30-35%. At the maximum dose there are 2 patients who both exceed the recommended dose of ICRU Report 62 by 107%.